8301 - 8350 of 8666 Results
Title
Year
-
OPENTitle: Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic miceJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-019-1636-8Best OA location URL: https://doi.org/10.1186/s12974-019-1636-8Citation Count: 119
-
OPENTitle: Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligaseJournal Name: AutophagyPublisher: Informa UK LimitedVol:Issue #:Start Page: 1End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2025.2531025Best OA location URL: https://doi.org/10.1080/15548627.2025.2531025Citation Count: 0
-
OPENTitle: The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBACJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 617Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.aav1256Best OA location URL: https://figshare.com/articles/journal_contribution/The_parkin-coregulated_gene_product_PACRG_promotes_TNF_signaling_by_stabilizing_LUBAC_/12860654Citation Count: 18
-
OPENTitle: Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasisJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 41Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embj.2020105531Best OA location URL: http://urn.fi/urn:nbn:fi-fe202301316706Citation Count: 23
- Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275W2024OPENTitle: Structural and Functional Characterization of the Most Frequent Pathogenic PRKN Substitution p.R275WJournal Name: CellsPublisher: MDPI AGVol: 13Issue #: 18Start Page: 1540End Page: 1540Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13181540Best OA location URL: https://doi.org/10.3390/cells13181540Citation Count: 2
-
OPENTitle: Incidence of Parkinson disease in North AmericaJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00410-yBest OA location URL: https://escholarship.org/uc/item/3pz049xwCitation Count: 220
-
OPENTitle: Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairmentJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1069411Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1069411/pdfCitation Count: 42
-
OPENTitle: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 919End Page: 927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26170Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4855523Citation Count: 282
-
OPENTitle: Predicting primary progressive aphasias with support vector machine approaches in structural MRI dataJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 14Issue #:Start Page: 334End Page: 343Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.02.003Best OA location URL: https://doi.org/10.1016/j.nicl.2017.02.003Citation Count: 50
-
OPENTitle: Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00482-4Best OA location URL: https://www.nature.com/articles/s41531-023-00482-4.pdfCitation Count: 19
- Engineered Axonal Tracts as “Living Electrodes” for Synaptic‐Based Modulation of Neural Circuitry2017OPENTitle: Engineered Axonal Tracts as “Living Electrodes” for Synaptic‐Based Modulation of Neural CircuitryJournal Name: Advanced Functional MaterialsPublisher: WileyVol: 28Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/adfm.201701183Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8152180Citation Count: 49
-
OPENTitle: Il-10 signaling reduces survival in mouse models of synucleinopathyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00169-8Best OA location URL: https://www.nature.com/articles/s41531-021-00169-8.pdfCitation Count: 12
-
RESTRICTEDTitle: Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science (P2.8-010)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-010Citation Count: 1
-
OPENTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Citation Count: 42
-
OPENTitle: Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity-resistant and obesity-prone ratsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 346Issue #:Start Page: 137End Page: 143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5860948Citation Count: 3
-
RESTRICTEDTitle: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402Citation Count: 0
-
RESTRICTEDTitle: Stereological investigation of 5-HT3 receptors in the substantia nigra and dorsal raphe nucleus in the ratJournal Name: Journal of Chemical NeuroanatomyPublisher: Elsevier BVVol: 111Issue #:Start Page: 101881End Page: 101881Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jchemneu.2020.101881Citation Count: 2
-
OPENTitle: SparkINFERNO: a scalable high-throughput pipeline for inferring molecular mechanisms of non-coding genetic variantsJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 36Issue #: 12Start Page: 3879End Page: 3881Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/bioinformatics/btaa246Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/36/12/3879/33437175/btaa246.pdfCitation Count: 13
-
OPENTitle: Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic casesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 58Issue #:Start Page: 183End Page: 190Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2013.05.017Best OA location URL: http://infoscience.epfl.ch/record/189244Citation Count: 48
-
RESTRICTEDTitle: Tandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson DiseaseJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 88Issue #: 3Start Page: 1856End Page: 1863Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.analchem.5b04227Citation Count: 80
-
RESTRICTEDTitle: Tissue transglutaminase in Alzheimer's disease – facts and fiction: a reply to “Tissue transglutaminase is a biochemical marker for Alzheimer's disease”Journal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 4Start Page: e5End Page: e9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.09.042Citation Count: 14
- Impulse control disorder in Parkinson’s disease is associated with abnormal frontal value signalling2023OPENTitle: Impulse control disorder in Parkinson’s disease is associated with abnormal frontal value signallingJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 9Start Page: 3676End Page: 3689Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awad162Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad162/50350389/awad162.pdfCitation Count: 13
-
RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0
-
RESTRICTEDTitle: Healthcare access and utilization of deep brain stimulation and supplementary care in black and white patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 140Issue #:Start Page: 108057End Page: 108057Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108057Citation Count: 0
-
OPENTitle: Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stressJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2313540121Best OA location URL: https://doi.org/10.1073/pnas.2313540121Citation Count: 31
- A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults2025OPENTitle: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adultsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251356503Best OA location URL: https://doi.org/10.1177/1877718x251356503Citation Count: 0
-
OPENTitle: Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expressionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00189-4Best OA location URL: https://www.nature.com/articles/s41531-021-00189-4.pdfCitation Count: 45
-
OPENTitle: Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicityJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 30Issue #: 23Start Page: 2332End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddab188Best OA location URL: https://academic.oup.com/hmg/article-pdf/30/23/2332/41163809/ddab188.pdfCitation Count: 11
-
OPENTitle: PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista JunctionsJournal Name: Molecular CellPublisher: Elsevier BVVol: 69Issue #: 5Start Page: 744End Page: 756.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.molcel.2018.01.026Best OA location URL: http://www.cell.com/article/S1097276518300558/pdfCitation Count: 100
-
OPENTitle: Neuroimaging and clinical predictors of fatigue in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 23Issue #:Start Page: 45End Page: 49Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.11.029Best OA location URL: http://doi.org/10.1016/j.parkreldis.2015.11.029Citation Count: 36
-
OPENTitle: Disease progression models for dominantly-inherited Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 5Start Page: 1244End Page: 1246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awy089Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5917766Citation Count: 3
-
RESTRICTEDTitle: Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 8Start Page: 3641End Page: 3652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02371-4Citation Count: 14
-
OPENTitle: Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s DiseaseJournal Name: PharmaceuticalsPublisher: MDPI AGVol: 16Issue #: 6Start Page: 883End Page: 883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ph16060883Best OA location URL: https://www.mdpi.com/1424-8247/16/6/883/pdf?version=1686821531Citation Count: 15
-
OPENTitle: Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System AtrophyJournal Name: The American Journal of PathologyPublisher: Elsevier BVVol: 178Issue #: 4Start Page: 1509End Page: 1516Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajpath.2011.01.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3078443Citation Count: 112
-
OPENTitle: Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 InhibitionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 760End Page: 773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27994Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8167931Citation Count: 89
-
OPENTitle: Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 136End Page: 148Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.004Best OA location URL: https://repositorio.uchile.cl/handle/2250/167345Citation Count: 145
-
OPENTitle: The importance of a healthy mouth in Parkinson's diseaseJournal Name: The LancetPublisher: Elsevier BVVol: 402Issue #: 10411Start Page: 1419End Page: 1420Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(23)01466-6Best OA location URL: https://hdl.handle.net/1871.1/ea12484d-8613-4ca6-a1c5-6d7e9a12513aCitation Count: 5
-
OPENTitle: S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body DementiaJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 42Issue #: 14Start Page: 3011End Page: 3024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1508-21.2022Best OA location URL: https://escholarship.org/uc/item/0n57v9mfCitation Count: 43
-
OPENTitle: Humanized Biomimetic Nanovesicles for Neuron TargetingJournal Name: Advanced SciencePublisher: WileyVol: 8Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202101437Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202101437Citation Count: 26
- Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice2021OPENTitle: Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic miceJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 30Issue #: 16Start Page: 1469End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddab118Best OA location URL: https://academic.oup.com/hmg/article-pdf/30/16/1469/39351981/ddab118.pdfCitation Count: 17
-
OPENTitle: Population fraction of Parkinson’s disease attributable to preventable risk factorsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00603-zBest OA location URL: https://www.nature.com/articles/s41531-023-00603-z.pdfCitation Count: 10
-
RESTRICTEDTitle: Randomized, Controlled Trial of Acupuncture for Fatigue in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 1027End Page: 1032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26597Citation Count: 74
-
OPENTitle: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3865178Citation Count: 63
-
OPENTitle: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron lossJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 164Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6592621Citation Count: 12
-
RESTRICTEDTitle: Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonismJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 395Issue #:Start Page: 115474End Page: 115474Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115474Citation Count: 0
-
OPENTitle: Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrilsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 129Issue #:Start Page: 67End Page: 78Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2019.05.012Best OA location URL: http://hdl.handle.net/11577/3309722Citation Count: 63
-
OPENTitle: The East Asian Parkinson Disease Genomics ConsortiumJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 12Start Page: 982End Page: 982Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00373-2Citation Count: 7
-
OPENTitle: Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein DestabilizationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 8Start Page: 5273End Page: 5286Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-018-1449-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-018-1449-2.pdfCitation Count: 18
-
RESTRICTEDTitle: Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 70Issue #:Start Page: 51End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.008Citation Count: 35
-
OPENTitle: The melanoma‐linked “redhead” MC1R influences dopaminergic neuron survivalJournal Name: Annals of NeurologyPublisher: WileyVol: 81Issue #: 3Start Page: 395End Page: 406Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6085083Citation Count: 49